Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Loeb

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult PatientsNicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
International Journal of Cancer|June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapyFariba Navid, Victor M Santana, Michael Neel, et al.
Nature Communications|January 28, 2026
Cycling molecular assemblies for Golgi imaging and disruptionWeiyi Tan, Qiuxin Zhang, Zhiyu Liu, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2024
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer FoundationAditi Dhir, Masanori Hayashi, Avery Bodlak, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult PatientsNicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
International Journal of Cancer|June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapyFariba Navid, Victor M Santana, Michael Neel, et al.
Nature Communications|January 28, 2026
Cycling molecular assemblies for Golgi imaging and disruptionWeiyi Tan, Qiuxin Zhang, Zhiyu Liu, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2024
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer FoundationAditi Dhir, Masanori Hayashi, Avery Bodlak, et al.
Pageof 12